Elena Kiseleva

Dr. Elena Kiseleva

orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 1994 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
GBGeorgy Bakalkin
Georgy Bakalkin
TYT Yakovleva
T Yakovleva
GSGalina Selivanova
Galina Selivanova
KMKristinn Magnússon
Kristinn Magnússon
LSL Szekely
L Szekely
KWK G Wiman
K G Wiman
The p53 tumor-suppressor protein has previously been shown to bind double-stranded and single-stranded DNA. We report that the p53 protein can bind single-stranded DNA ends and catalyze DNA renaturation and DNA strand transfer. Both a bacterially expressed wild-type p53 protein and a glutathione S-transferase-wild-type p53 fusion protein catalyzed renaturation of different short (25- to 76-nt) complementary single-stranded DNA fragments and promoted strand transfer between short (36-bp) duplex DNA and complementary single-stranded DNA. Mutant p53 fusion proteins carrying amino acid substitutions Glu-213, Ile-237, or Tyr-238, derived from mutant p53 genes of Burkitt lymphomas, failed to catalyze these reactions. Wild-type p53 had significantly higher binding affinity for short (36- to 76-nt) than for longer (> or = 462-nt) single-stranded DNA fragments in an electrophoretic mobility-shift assay. Moreover, electron microscopy showed that p53 preferentially binds single-stranded DNA ends. Binding of DNA ends to p53 oligomers may allow alignment of complementary strands. These findings suggest that p53 may play a direct role in the repair of DNA breaks, including the joining of complementary single-stranded DNA ends.

1 January 1996 in Cell
Verified
Journal Article
Closed access
NVNeus Visa
Neus Visa
AAAlla T Alzhanova-Ericsson
Alla T Alzhanova-Ericsson
XSXin Sun
Xin Sun
EKElena Kiseleva
Elena Kiseleva
BBBirgitta Björkroth
Birgitta Björkroth
BDBertil Daneholt
Bertil Daneholt

14 April 2016 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
ENEvgeny D. Nekrasov
Evgeny D. Nekrasov
VVVladimir Vigont
Vladimir Vigont
SKSergey Klyushnikov
Sergey Klyushnikov
OLOlga S. Lebedeva
Olga S. Lebedeva
EVEkaterina M. Vassina
Ekaterina M. Vassina
SKSergey Kiselev
Sergey Kiselev
Huntington’s disease (HD) is an incurable hereditary neurodegenerative disorder, which manifests itself as a loss of GABAergic medium spiny (GABA MS) neurons in the striatum and caused by an expansion of the CAG repeat in exon 1 of the huntingtin gene. There is no cure for HD, existing pharmaceutical can only relieve its symptoms. Here, induced pluripotent stem cells were established from patients with low CAG repeat expansion in the huntingtin gene, and were then efficiently differentiated into GABA MS-like neurons (GMSLNs) under defined culture conditions. The generated HD GMSLNs recapitulated disease pathology in vitro, as evidenced by mutant huntingtin protein aggregation, increased number of lysosomes/autophagosomes, nuclear indentations, and enhanced neuronal death during cell aging. Moreover, store-operated channel (SOC) currents were detected in the differentiated neurons, and enhanced calcium entry was reproducibly demonstrated in all HD GMSLNs genotypes. Additionally, the quinazoline derivative, EVP4593, reduced the number of lysosomes/autophagosomes and SOC currents in HD GMSLNs and exerted neuroprotective effects during cell aging. Our data is the first to demonstrate the direct link of nuclear morphology and SOC calcium deregulation to mutant huntingtin protein expression in iPSCs-derived neurons with disease-mimetic hallmarks, providing a valuable tool for identification of candidate anti-HD drugs. Our experiments demonstrated that EVP4593 may be a promising anti-HD drug.

30 June 2009 in The Plant Journal
Verified
Journal Article
Closed access
PDF file
JFJindriska Fiserova
Jindriska Fiserova
EKElena Kiseleva
Elena Kiseleva
MGMartin Goldberg
Martin Goldberg

11 February 1995 in Nucleic Acids Research
Verified
Journal Article
Closed access
PDF file
GBGeorgy Bakalkin
Georgy Bakalkin
GSGalina Selivanova
Galina Selivanova
TYTatjana Yakovleva
Tatjana Yakovleva
EKElena Kiseleva
Elena Kiseleva
Elena KashubaElena Kashuba
Elena Kashuba
KWKlas G. Wiman
Klas G. Wiman
We have previously reported that wild-type p53 can bind single-stranded (ss) DNA ends and catalyze renaturation of ss complementary DNA molecules. Here we demonstrate that p53 can also bind to internal segments of ss DNA molecules via a binding site (internal DNA site) distinct from the binding site for DNA ends (DNA end site). Using p53 deletion mutants, the internal DNA site was mapped to the central region (residues 99–307), while the DNA end site was mapped to the C-terminal domain (residues 320–393) of the p53 protein. The internal DNA site can be activated by the binding of ss DNA ends to the DNA end site. The C-terminal domain alone was sufficient to catalyze DNA renaturation, although the central domain was also involved in promotion of renaturation by the full-length protein. Our results suggest that the interaction of the C-terminal tail of p53 with ss DNA ends generated by DNA damage in vivo may lead to activation of non-specific ss DNA binding by the central domain of p53.

15 May 2004 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
EKElena Kiseleva
Elena Kiseleva
SDSheona P. Drummond
Sheona P. Drummond
MGMartin Goldberg
Martin Goldberg
SRSandra A. Rutherford
Sandra A. Rutherford
TATerence D. Allen
Terence D. Allen
KWKatherine L. Wilson
Katherine L. Wilson
We imaged the interiors of relatively intact Xenopus oocyte nuclei by field emission scanning electron microscopy (feSEM) and visualized a network of filaments that attach to nuclear pore complexes and extend throughout the nucleus. Within the nucleus, these `pore-linked filaments' (PLFs) were embedded into spherical structures 100 nm to ∼5 μm in diameter. A subset of spheres was identified as Cajal bodies by immuno-gold labeling; the rest were inferred to be nucleoli and snurposomes both of which are abundant in Xenopus oocyte nuclei. Most PLFs were independent of chromatin. The thickness of a typical PLF was 40 nm (range, ∼12-100 nm), including the 4 nm chromium coat. PLFs located inside the nucleus merged, bundled and forked, suggesting architectural adaptability. The PLF network collapsed upon treatment with latrunculin A, which depolymerizes actin filaments. Jasplakinolide, which stabilizes actin filaments, produced PLFs with more open substructure including individual filaments with evenly-spaced rows of radially projecting short filaments. Immuno-gold labeling of untreated oocyte nuclei showed that actin and protein 4.1 each localized on PLFs. Protein 4.1-gold epitopes were spaced at ∼120 nm intervals along filaments, and were often paired (∼70 nm apart) at filament junctions. We suggest that protein 4.1 and actin contribute to the structure of a network of heterogeneous filaments that link nuclear pore complexes to subnuclear organelles, and discuss possible functions for PLFs in nuclear assembly and intranuclear traffic.